CellProtect Holding AG in Liquidation
Company Overview
Previous Company Names
- Alphaptosis Group Holding AG
- (Alphaptosis Group Holding Ltd) (Alphaptosis Group Holding SA)
- CellProtect Holding AG
Management
Martin Müller-Wolf
Zug
Chairperson of the board
Individual signing authority
Christiane Müller-Wolf
Zug
Member of the board
Individual signing authority
Rolf Axel Zander
Lübeck
Vice-chairperson of the board managing member of the board
Joint signing authority (any two to sign) joint signing authority (any two to sign)
Peter Dürolf
Hamburg
Managing member of the board
Joint signing authority (any two to sign)
Anne von Brauchitsch
Eutin
Chairperson of the board
Joint signing authority (any two to sign)
Axel Zander
Lübeck-Travemünde
Member of the board
Joint signing authority (any two to sign)
Wolfgang Dowie
München
Member of the board
Joint signing authority (any two to sign)
Rosario De Carlo
Freienbach
Having right to sign
Individual signing authority
Peter Hertig
St. Gallen
Member of the board
Individual signing authority
Dr. Kiessling
Berlin, DE
Member of the board
Joint signing authority (any two to sign)
Erich Sager
Winterthur
Member of the board
Joint signing authority (any two to sign)
Paul Nakagaki
Nusshof
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Address & Locations
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 14235 | 05.09.2023 | 174 | 08.09.2023 | 1005834018 |
| 2 | 14425 | 14.10.2020 | 203 | 19.10.2020 | 1005002628 |
| 3 | 14368 | 13.10.2020 | 202 | 16.10.2020 | 1005001585 |
| 4 | 13836 | 02.10.2020 | 195 | 07.10.2020 | 1004994459 |
| 5 | B13273 | 24.09.2020 | B189 | 29.09.2020 | 1004988041 |
| 6 | 5140 | 11.04.2018 | 72 | 16.04.2018 | 4172903 |
| 7 | 15240 | 29.11.2017 | 235 | 04.12.2017 | 3906565 |
| 8 | 10668 | 21.08.2017 | 163 | 24.08.2017 | 3712851 |
| 9 | 14959 | 29.11.2016 | 235 | 02.12.2016 | 3198075 |
| 10 | 5545 | 26.04.2016 | 83 | 29.04.2016 | 2807929 |
Company Purpose
Erwerb, Verkauf, Halten und Verwalten von Beteiligungen an anderen Gesellschaften, insbesondere von Gesellschaften mit Tätigkeitsgebiet in der Forschung, Entwicklung und Verwertung von pharmazeutischen Wirkstoffen; vollständige Zweckumschreibung gemäss Statuten